The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA's Overreach on Compounded Peptides FDA Peptide Reclassification 2026: What It Means for Providers BPC 157: Miracle Healing Peptide or Hidden Danger? FDA moves toward easing restrictions on certain peptides BioPharma Dive